Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics' Q2 Revenues More Than Double

NEW YORK (GenomeWeb News) – Cellular Dynamics International today reported that its second quarter revenues increased 123 percent year over year, driven by sales of its iCell products.

The Madison, Wis.-based firm brought in total revenues of $2.8 million for the three months ended June 30, compared to $1.3 million for the second quarter of 2012. It said that the revenue growth was primarily attributable to growth in unit sales of its iCell human induced pluripotent stem cell-derived products.

It also noted that it reported the first product revenues of $170,000 from its MyCell products line. Those products are used for iPS cell reprogramming, genetic engineering, and cell differentiation.

CDI reported a net loss of $5.1 million, or $2.92 per share, for the quarter, compared to a net loss of $6.2 million, or $3.58 per share, for the second quarter of 2012.

The firm's R&D spending climbed 3 percent to $3.9 million from $3.8 million, and its SG&A expenses also rose 3 percent to $3.3 million from $3.2 million.

It finished the quarter with $33.5 million in cash and cash equivalents. But, subsequent to the end of the quarter, CDI completed an initial public offering that brought in net proceeds of around $43 million.

In Thursday morning trade on the Nasdaq, shares of CDI were up a fraction of 1 percent at $12.75.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.